Association between serum vitamin D, hs-CRP, and prooxidant-antioxidant balance with anthropometric and biochemical parameters in patients with diabetic foot ulcers
, 4, 2, 3, 2, 5, 2, 12
Abstract
Background. Oxidative balance and inflammatory processes affect wound healing phases, and their disruption is connected with delayed wound healing. The present study aimed to assess the association between serum hs-CRP, prooxidant-antioxidant Balance (PAB), and vitamin D with anthropometric and biochemical parameters in patients with diabetic foot ulcers (DFU).
Methods. Thirty-two patients with DFU were included in this study. The Spearman correlation coefficient was used to evaluate the bivariate relationship between serum hs-CRP, PAB, and vitamin D with anthropometric characteristics, glycemic status, lipid profiles, homocysteine level, liver, and kidney function tests.
Results. Our data showed a significant positive association between serum hs-CRP and insulin (r = 0.417, P = 0.027), uric acid (r = 0.629, P = 0.001), creatinine (r = 0.431, P = 0.022), erythema (r = 0.36, P = 0.049), and ESR (r = 0.560, P = 0.002). Moreover, hs-CRP negatively correlated with FBS (r = –0.427, P = 0.023), total bilirubin (r = –0.639, P = 0.001), direct bilirubin (r = –0.445, P = 0.033), LDL-cholesterol (r = –0.405, P = –0.032), BMI (r = –0.398, P = 0.033) and HTN (r = –0.450, P = 0.014). Serum PAB value negatively correlated with patients age (r = –0.460, P = 0.027), and BMI (r = –0.442, P = 0.035), and positively associated with insulin level (r = 0.431, P = 0.040). A significant positive association between serum vitamin D with patient sex (r = 0.379, P = 0.047), and QUICKI (r = 0.456, P = 0.029), and negative correlation with HbA1c (r = –0.381, P = 0.045) were also determined.
Conclusions. This study demonstrated that serum hs- CRP, PAB, and vitamin D are significantly associated with some anthropometric and biochemical parameters with important clinical value in patients with DFU. Low levels of vitamin D and high levels of hs-CRP and PAB may have an important role in the pathogenesis of DFU.
Keywords: associationvitamin Dhs-CRPoxidant-antioxidant balancediabetic foot ulcers
References
- Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001; 414(6865): 782–787.
- Zimmet P, Alberti KG, Magliano DJ, et al. Diabetes mellitus statistics on prevalence and mortality: facts and fallacies. Nat Rev Endocrinol. 2016; 12(10): 616–622.
- Dee T, Sukartini T, Probowati R. Factors associated with foot ulcer among diabetic patients. Int J Nurs Sci Health Serv. 2020; 3(3): 771–776.
- Martins-Mendes D, Monteiro-Soares M, Boyko EJ, et al. The independent contribution of diabetic foot ulcer on lower extremity amputation and mortality risk. J Diabetes Complications. 2014; 28(5): 632–638.
- Singh SK, Sahay RK, Krishna A. Oxidative stress in diabetic foot ulcer. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2008; 2(2): 109–113.
- Zubair M, Malik A, Meerza D, et al. 25-Hydroxyvitamin D [25(OH)D] levels and diabetic foot ulcer: is there any relationship? Diabetes Metab Syndr. 2013; 7(3): 148–153.
- Yarahmadi A, Zal F, Bolouki A. Protective effects of quercetin on nicotine induced oxidative stress in 'HepG2 cells'. Toxicol Mech Methods. 2017; 27(8): 609–614.
- Sies H, Berndt C, Jones DP. Oxidative stress. Annu Rev Biochem. 2017; 86: 715–748.
- Yarahmadi A, Khademi F, Mostafavi-Pour Z, et al. In-vitro analysis of glucose and quercetin effects on m-TOR and Nrf-2 expression in HepG2 cell line (diabetes and cancer connection). Nutr Cancer. 2018; 70(5): 770–775.
- Khan R, Ooi XY, Parvus M, et al. Advanced glycation end products: formation, role in diabetic complications, and potential in clinical applications. The Eye and Foot in Diabetes. 2020.
- Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018; 9: 754.
- Ahmad J, Zubair M, Malik A, et al. Cathepsin-D, adiponectin, TNF-α, IL-6 and hsCRP plasma levels in subjects with diabetic foot and possible correlation with clinical variables: a multicentric study. Foot (Edinb). 2012; 22(3): 194–199.
- Windgassen EB, Funtowicz L, Lunsford TN, et al. C-reactive protein and high-sensitivity C-reactive protein: an update for clinicians. Postgrad Med. 2011; 123(1): 114–119.
- Rifai N, Ridker P. High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clinical Chemistry. 2001; 47(3): 403–411.
- Pearle AD, Scanzello CR, George S, et al. Elevated high-sensitivity C-reactive protein levels are associated with local inflammatory findings in patients with osteoarthritis. Osteoarthritis Cartilage. 2007; 15(5): 516–523.
- Hamidi Alamdari D, Bagheri Moghaddam A, Amini S, et al. The application of a reduced dye used in orthopedics as a novel treatment against coronavirus (COVID-19): a suggested therapeutic protocol. Arch Bone Jt Surg. 2020; 8(Suppl1): 291–294.
- Dai J, Jiang C, Chen H, et al. Vitamin D and diabetic foot ulcer: a systematic review and meta-analysis. Nutr Diabetes. 2019; 9(1): 8.
- Alamdari DH, Paletas K, Pegiou T, et al. A novel assay for the evaluation of the prooxidant-antioxidant balance, before and after antioxidant vitamin administration in type II diabetes patients. Clin Biochem. 2007; 40(3-4): 248–254.
- Sikka M, Tandon R, Rusia U, et al. Validation of ESR analyzer using Westergren ESR method. Indian J Pathol Microbiol. 2007; 50: 634.
- Borai A, Livingstone C, Kaddam I, et al. Selection of the appropriate method for the assessment of insulin resistance. BMC Med Res Methodol. 2011; 11: 158.
- Aronson D. Hyperglycemia and the pathobiology of diabetic complications. Adv Cardiol. 2008; 45: 1–16.
- Yeh ET, Anderson HV, Pasceri V, et al. C-reactive protein: linking inflammation to cardiovascular complications. Circulation. 2001; 104(9): 974–975.
- Liang YJ, Liu YC, Chen CY, et al. Comparison of PPARδ and PPARγ in inhibiting the pro-inflammatory effects of C-reactive protein in endothelial cells. Int J Cardiol. 2010; 143(3): 361–367.
- Zubair M, Malik A, Ahmad J. Plasma adiponectin, IL-6, hsCRP, and TNF-α levels in subject with diabetic foot and their correlation with clinical variables in a North Indian tertiary care hospital. Indian J Endocrinol Metab. 2012; 16(5): 769–776.
- Mi Qi, Rivière B, Clermont G, et al. Agent-based model of inflammation and wound healing: insights into diabetic foot ulcer pathology and the role of transforming growth factor-beta1. Wound Repair Regen. 2007; 15(5): 671–682.
- Hotamisligil GS. Inflammatory pathways and insulin action. Int J Obes Relat Metab Disord. 2003; 27 Suppl 3: S53–S55.
- Jung CH, Kim KJ, Kim BY, et al. Relationship between vitamin D status and vascular complications in patients with type 2 diabetes mellitus. Nutr Res. 2016; 36(2): 117–124.
- Buhary BM, Almohareb O, Aljohani N, et al. Association of glycosylated hemoglobin levels with vitamin D status. J Clin Med Res. 2017; 9(12): 1013–1018.
- Lee CJ, Iyer G, Liu Y, et al. The effect of vitamin D supplementation on glucose metabolism in type 2 diabetes mellitus: A systematic review and meta-analysis of intervention studies. J Diabetes Complications. 2017; 31(7): 1115–1126.